MicroRNA-9 Enhanced Cisplatin Sensitivity in Nonsmall Cell Lung Cancer Cells by Regulating Eukaryotic Translation Initiation Factor 5A2

<div><b>Cisplatin sensitivity in NSCLC cells</b>. (a) CCK-8 determination of cell viability after treatment with 0, 0.3125, 0.625, 1.25, 2.5, or 5 <i>μ</i>g/mL cisplatin. (b) RT-qPCR detection of miR-9 expression in cells. U6 was used as an internal control.</div>

BioMed Research International

fig1

Figure 1

Figure 1: MicroRNA-9 Enhanced Cisplatin Sensitivity in Nonsmall Cell Lung Cancer Cells by Regulating Eukaryotic Translation Initiation Factor 5A2 